Canada markets closed

Emerald Health Therapeutics, Inc. (EMH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3350+0.0100 (+3.08%)
At close: 3:59PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 568.68M
Enterprise Value 325.6M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.28
Price/Book (mrq)0.84
Enterprise Value/Revenue 31.97
Enterprise Value/EBITDA 6-0.93

Trading Information

Stock Price History

Beta (5Y Monthly) 0.85
52-Week Change 332.65%
S&P500 52-Week Change 326.90%
52 Week High 30.5300
52 Week Low 30.1200
50-Day Moving Average 30.2894
200-Day Moving Average 30.2288

Share Statistics

Avg Vol (3 month) 3756.22k
Avg Vol (10 day) 31.05M
Shares Outstanding 5205.03M
Float 165.84M
% Held by Insiders 119.46%
% Held by Institutions 10.78%
Shares Short (Feb. 11, 2021) 46.78M
Short Ratio (Feb. 11, 2021) 45.79
Short % of Float (Feb. 11, 2021) 4N/A
Short % of Shares Outstanding (Feb. 11, 2021) 43.31%
Shares Short (prior month Jan. 14, 2021) 4313.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep. 08, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-242.99%

Management Effectiveness

Return on Assets (ttm)-9.97%
Return on Equity (ttm)-91.66%

Income Statement

Revenue (ttm)13.02M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-63.70%
Gross Profit (ttm)-10.79M
EBITDA -27.46M
Net Income Avi to Common (ttm)-125.26M
Diluted EPS (ttm)-0.6960
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.67M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)28.42M
Total Debt/Equity (mrq)35.45
Current Ratio (mrq)2.97
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-5.13M
Levered Free Cash Flow (ttm)-1.95M